Abstract
Background The 2019 novel coronavirus or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak was declared a pandemic by the World Health Organization (WHO) in March 2020. Almost two years later (early-February 2022), the WHO reported over 383 million cases of the disease caused by the virus with over 5.6 million deaths worldwide. Debate regarding routes of transmission was substantial early in the pandemic; however, airborne transmission emerged as an important consideration. Infectious airborne agents can spread within the built environment through heating, ventilation, and air conditioning (HVAC) systems. Multiple features of HVAC systems can influence transmission (e.g., ventilation, filtration, ultraviolet radiation, humidity). Understanding how HVAC features influence airborne transmission is critical to mitigate the spread of infectious agents.
Objective Given airborne transmission of SARS-CoV-2, an overview of reviews was conducted to understand what is already known from the scientific literature about how virus transmission may be affected by HVAC design features in the built environment.
Methods Ovid MEDLINE and Compendex were searched from inception to January 2021. Two reviewers independently screened titles and abstracts and full text of potentially relevant reviews, using a priori inclusion criteria. Inclusion criteria were systematic reviews examining effects of HVAC design features on virus transmission. Two reviewers independently assessed methodological quality using AMSTAR2.
Results Searching identified 361 citations, 45 were potentially relevant, and 7 were included. Reviews were published between 2007 and 2021, and included 47 virus studies. Two earlier reviews (2007, 2016) of 21 studies found sufficient evidence that mechanical ventilation (airflow patterns, ventilation rates) plays a role in airborne transmission; however, both found insufficient evidence to quantify minimum mechanical ventilation requirements. One review (2017) of 9 studies examining humidity and indoor air quality found that influenza virus survival was lowest between 40% and 80% relative humidity; authors noted that ventilation rates were a confounding variable. Two reviews (2021) examined mitigation strategies for coronavirus transmission, finding that transmission decreased with increasing temperature and relative humidity. One review (2020) identified 14 studies examining coronavirus transmission in air conditioning systems, finding HVAC systems played a role in virus spread during previous coronavirus outbreaks. One review (2020) examined virus transmission interventions on public ground transportation, finding ventilation and filtration to be effective.
Conclusions Seven reviews synthesizing 47 studies demonstrate a role for HVAC in mitigating airborne virus transmission. Ventilation, humidity, temperature, and filtration can play a role in viability and transmission of viruses, including coronaviruses. Recommendations for minimum standards were not possible due to few studies investigating a given HVAC parameter. This overview examining HVAC design features and their effects on airborne transmission of viruses serves as a starting point for future systematic reviews and identifying priorities for primary research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is funded by a Canadian Institutes of Health Research (CIHR) Operating Grant: Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity [https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=422567; grant number: not applicable]. Dr. Hartling is supported by a Canada Research Chair (Tier 1) in Knowledge Synthesis and Translation. The funders had no role in the project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable because this is an overview of reviews.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Minor revisions to abstract and manuscript.
Data Availability
No additional data available. All data are available in the manuscript and the supplemental material.
Abbreviations
- ACH
- air changes per hour
- COVID-19
- coronavirus disease 2019
- HEPA
- high efficiency particulate air
- HVAC
- heating, ventilation and air conditioning
- MERS-CoV
- Middle East respiratory syndrome coronavirus
- MERV
- minimum efficiency reporting value
- RH
- relative humidity
- SARS-CoV-1
- severe acute respiratory syndrome coronavirus 1
- SARS-CoV-2
- severe acute respiratory syndrome coronavirus 2
- UV
- ultraviolet
- UVGI
- ultraviolet germicidal irradiation
- WHO
- World Health Organization
